MA56505A - Inhibiteurs macrocycliques de mcl-1 - Google Patents
Inhibiteurs macrocycliques de mcl-1Info
- Publication number
- MA56505A MA56505A MA056505A MA56505A MA56505A MA 56505 A MA56505 A MA 56505A MA 056505 A MA056505 A MA 056505A MA 56505 A MA56505 A MA 56505A MA 56505 A MA56505 A MA 56505A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibitors
- mcl
- macrocyclic
- macrocyclic mcl
- Prior art date
Links
- 101001056180 Homo sapiens Induced myeloid leukemia cell differentiation protein Mcl-1 Proteins 0.000 title 1
- 102100026539 Induced myeloid leukemia cell differentiation protein Mcl-1 Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19181605 | 2019-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56505A true MA56505A (fr) | 2022-04-27 |
Family
ID=67001598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056505A MA56505A (fr) | 2019-06-21 | 2020-06-18 | Inhibiteurs macrocycliques de mcl-1 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220306653A1 (fr) |
| EP (1) | EP3986902B1 (fr) |
| JP (1) | JP7617861B2 (fr) |
| KR (1) | KR20220024694A (fr) |
| CN (1) | CN114641481B (fr) |
| AU (1) | AU2020296918A1 (fr) |
| BR (1) | BR112021025732A2 (fr) |
| ES (1) | ES2975083T3 (fr) |
| MA (1) | MA56505A (fr) |
| MX (1) | MX2021015770A (fr) |
| WO (1) | WO2020254471A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020063792A1 (fr) * | 2018-09-30 | 2020-04-02 | 江苏恒瑞医药股份有限公司 | Dérivé macrocyclique d'indole, son procédé de préparation et son application en médecine |
| TWI749404B (zh) * | 2018-11-22 | 2021-12-11 | 大陸商蘇州亞盛藥業有限公司 | 作為mcl-1抑制劑的大環吲哚 |
| CA3158733A1 (fr) | 2019-11-21 | 2021-05-27 | Pilar Calvo | Procedes de traitement du cancer du poumon a petites cellules avec des formulations de lurbinectedine |
| CA3157590A1 (fr) * | 2019-11-21 | 2021-05-27 | Janssen Pharmaceutica Nv | Derives de sulfonyle macrocycliques utilises en tant qu'inhibiteurs de mcl-1 |
| CN115151551B (zh) * | 2020-02-21 | 2024-10-25 | 詹森药业有限公司 | 作为mcl-1抑制剂的大环吲哚衍生物 |
| CN116848126A (zh) * | 2021-02-12 | 2023-10-03 | 詹森药业有限公司 | 大环1,3-桥联的6-氯-7-吡唑-4-基-1h-吲哚-2-羧酸酯和6-氯-7-嘧啶-5-基-1h-吲哚-2-羧酸酯衍生物作为mcl-1抑制剂用于治疗癌症 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015112806A2 (fr) * | 2014-01-24 | 2015-07-30 | Tp Therapeutics, Inc. | Macrocycles de diaryle en tant que modulateurs de protéines kinases |
| JO3474B1 (ar) * | 2014-08-29 | 2020-07-05 | Amgen Inc | مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1 |
| CR20180499A (es) * | 2016-04-22 | 2019-01-25 | Astrazeneca Ab | Inhibidores de mcl1 macrocicliclos para tratar el cancer |
| TW201904976A (zh) * | 2017-03-31 | 2019-02-01 | 瑞典商阿斯特捷利康公司 | Ｍｃｌ-１抑制劑及其使用方法 |
| TWI781996B (zh) | 2017-03-31 | 2022-11-01 | 瑞典商阿斯特捷利康公司 | 合成ｍｃｌ-１抑制劑之方法 |
| MX2020001719A (es) * | 2017-08-15 | 2020-11-06 | Abbvie Inc | Inhibidores macrocíclicos de mcl-1 y metodos de uso. |
| WO2020063792A1 (fr) | 2018-09-30 | 2020-04-02 | 江苏恒瑞医药股份有限公司 | Dérivé macrocyclique d'indole, son procédé de préparation et son application en médecine |
| TWI749404B (zh) | 2018-11-22 | 2021-12-11 | 大陸商蘇州亞盛藥業有限公司 | 作為mcl-1抑制劑的大環吲哚 |
-
2020
- 2020-06-18 MA MA056505A patent/MA56505A/fr unknown
- 2020-06-18 WO PCT/EP2020/066890 patent/WO2020254471A1/fr not_active Ceased
- 2020-06-18 ES ES20734336T patent/ES2975083T3/es active Active
- 2020-06-18 EP EP20734336.9A patent/EP3986902B1/fr active Active
- 2020-06-18 JP JP2021575909A patent/JP7617861B2/ja active Active
- 2020-06-18 MX MX2021015770A patent/MX2021015770A/es unknown
- 2020-06-18 US US17/618,995 patent/US20220306653A1/en not_active Abandoned
- 2020-06-18 AU AU2020296918A patent/AU2020296918A1/en not_active Abandoned
- 2020-06-18 KR KR1020227001787A patent/KR20220024694A/ko not_active Withdrawn
- 2020-06-18 BR BR112021025732A patent/BR112021025732A2/pt unknown
- 2020-06-18 CN CN202080059643.7A patent/CN114641481B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP3986902C0 (fr) | 2024-01-24 |
| CN114641481A (zh) | 2022-06-17 |
| AU2020296918A1 (en) | 2022-02-17 |
| WO2020254471A1 (fr) | 2020-12-24 |
| EP3986902A1 (fr) | 2022-04-27 |
| JP2022537393A (ja) | 2022-08-25 |
| EP3986902B1 (fr) | 2024-01-24 |
| CA3143613A1 (fr) | 2020-12-24 |
| MX2021015770A (es) | 2022-04-12 |
| BR112021025732A2 (pt) | 2022-04-12 |
| ES2975083T3 (es) | 2024-07-03 |
| KR20220024694A (ko) | 2022-03-03 |
| JP7617861B2 (ja) | 2025-01-20 |
| CN114641481B (zh) | 2024-07-30 |
| US20220306653A1 (en) | 2022-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4029868B1 (fr) | Inhibiteurs de mcl-1 | |
| EP4007752C0 (fr) | Inhibiteurs de kif18a | |
| EP4007753C0 (fr) | Inhibiteurs de kif18a | |
| IL283639A (en) | Kif18a inhibitors | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| PT3958977T (pt) | Derivados de camptotecina | |
| EP4007756C0 (fr) | Inhibiteurs de kif18a | |
| EP4051676A4 (fr) | Inhibiteurs de bcl-2 | |
| IL292161A (en) | New methylquinazolinone derivatives | |
| EP3788042A4 (fr) | Inhibiteurs de bcl-2 | |
| EP3801503A4 (fr) | Inhibiteurs de sarm1 | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| IL290561A (en) | Alkynyl quinazoline compounds | |
| LT3445767T (lt) | Makrocikliniai mcl-1 inhibitoriai, skirti vėžio gydymui | |
| EP3980011A4 (fr) | Inhibiteurs de sarm1 | |
| MA52809A (fr) | Inhibiteurs de sarm1 | |
| PT3746446T (pt) | Inibidores de prc2 | |
| EP3883573A4 (fr) | Inhibiteurs macrocycliques de dyrk1a | |
| EP3817736A4 (fr) | Inhibiteurs de pikfyve | |
| PL4013751T3 (pl) | Pochodne 2-hydroksycykloalkano-1-karbamoilu | |
| DK3783000T3 (da) | Makrocyklisk kinasehæmmer | |
| DK3898637T3 (da) | Rapamycin-derivater | |
| EP3986902C0 (fr) | Inhibiteurs macrocycliques de mcl-1 | |
| EP4077334C0 (fr) | Dérivés furoindazole | |
| EP4021904C0 (fr) | Dérivés d'alpha-d-galactopyranoside |